Elbit Systems Ltd. (ESLT) is Israel's largest defense electronics company, supplying airborne, land and naval systems spanning electro-optics, electronic warfare, unmanned aircraft, precision munitions, command-and-control and cyber. Shares closed the prior session at $680.74 and were trading at $723.86 on Tuesday, a gain of 6.33% and a confirmed move to the upside. The catalyst was unambiguous: a third-quarter earnings beat, a record order backlog and a 2027 outlook that exceeded conservative expectations, reinforced by management commentary on how Israel's changing procurement relationship with Washington could expand the company's addressable market.
Revenue rose 17.2% year over year to $2.252 billion, with adjusted operating income climbing 30.7% to $244.1 million and the adjusted operating margin expanding to 10.8% from 9.7% — the fourth consecutive quarter above management's long-standing double-digit target. Adjusted net income reached $210 million, or $4.36 per share, versus $3.35 a year earlier. GAAP net income rose 33.4% to $177.9 million.
Segment performance was broad. ISTAR and electronic warfare revenue grew 32% on strong laser, maritime and electro-optic sales, while Land and Armaments rose 28% on ammunition demand in Israel. C4I and Cyber added 11%. Free cash flow of $276 million represented cash conversion above 150%, and nine-month operating cash flow of $862.5 million already exceeds the full-year 2025 figure.
The $33 billion backlog is the headline number for a company with a market capitalization near $34 billion — roughly 3.7 years of revenue at the current run rate. Europe drove the largest sequential increase, and management guided 2027 revenue growth in the high-teens range with continued margin improvement over 2026. That combination of contracted visibility and margin expansion is what justified the re-rating rather than a one-quarter earnings blip. The quarter also followed a steady stream of awards, including a $260 million PULS rocket artillery order from a European NATO member announced Nov. 12.
Chief Executive Bezhalel Machlis told Reuters that the termination of Washington's roughly $3.8 billion annual military aid program after this year could benefit Elbit, since Israel will need to produce domestically some of what it currently buys from U.S. suppliers. Guided munitions were cited as one candidate. The company invests about 6.5% of revenue — close to $600 million annually — in research and development. This is a long-dated opportunity rather than near-term revenue, but it gave buyers a thematic justification to look past valuation.
The gain was idiosyncratic. The S&P 500 was down about 1.4%, the iShares U.S. Aerospace & Defense ETF (ITA) slipped 0.3%, and the SPDR S&P Aerospace & Defense ETF (XAR) fell 1.2%, while RTX rose 1.4% and LMT added 0.7%. Elbit's advance was therefore not sector sympathy.
Trading activity was not stretched. Roughly 21,000 shares had changed hands by late afternoon against an average of about 35,000 over the past 70 sessions, with most of the flow concentrated in the opening hour after the stock gapped to $727. The session high of $738.86 failed to hold, and the close sits well below the late-October peak near $807, leaving the shares in recovery mode after a 16% slide from Oct. 29 to Nov. 16.
The score runs from 0, meaning no meaningful news and a move that is normal for the stock, to 100, meaning transformative news and an extreme, rare price move. Elbit's score is 54 out of 100.
On the news side, a clear quarterly beat, a record backlog and raised forward guidance represent a major fundamental development for a company of this size, though not a transformative one. On the price side, the 6.33% advance was about 3.3 times the stock's typical absolute daily move of 1.9%, and only three of the prior 69 sessions produced a larger swing. A strong catalyst combined with a moderately unusual move lands the score in the middle of the scale.
Attention now shifts to fourth-quarter and full-year 2026 results, typically reported in the first quarter, where investors will test whether production capacity expansions can support the guided 17%–19% growth without compressing margins below 10.8%. The $1.00 dividend has a record date of Dec. 21 and pays Jan. 4. Also worth tracking: the pace of European order intake, the timing of the compensation agreement with Israel's Ministry of Defense for delayed payments, currency and supply-chain pressure, and whether the U.S. aid transition proceeds on the schedule announced. Execution risk remains meaningful given the shares trade at a premium multiple and sit below their October highs.
Tickeron maintains hundreds of AI trading bots spanning thousands of tickers, and the Trending AI Robots page curates only those performing strongest under current market conditions. The listed bots differ by strategy, timeframe, performance metrics and the symbols they trade, so performance comparisons should be read alongside each bot's own risk profile. It is a practical starting point for traders evaluating automated strategies in a market where company-specific gaps like today's are common.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
ESLT's Aroon Indicator triggered a bullish signal on November 09, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 272 similar instances where the Aroon Indicator showed a similar pattern. In 212 of the 272 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 78%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 42 of 56 cases where ESLT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
Following a +8.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where ESLT advanced for three days, in 242 of 348 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
ESLT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The 10-day RSI Indicator for ESLT moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 43 similar instances where the indicator moved out of overbought territory. In 22 of the 43 cases, the stock moved lower in the following days. This puts the odds of a move lower at 51%.
The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ESLT as a result. In 50 of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 53%.
The Moving Average Convergence Divergence Histogram (MACD) for ESLT turned negative on November 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 27 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 51%.
ESLT moved below its 50-day moving average on November 13, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ESLT crossed bearishly below the 50-day moving average on November 12, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 54%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ESLT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 49%.
The Tickeron Profit vs. Risk Rating rating for this company is 24 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.
The Tickeron SMR rating for this company is 55 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. ESLT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 64 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 94 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.254) is normal, around the industry mean (5.050). P/E Ratio (49.860) is within average values for comparable stocks, (17.247). ESLT's Projected Growth (PEG Ratio) (11.650) is slightly higher than the industry average of (3.110). Dividend Yield (0.006) settles around the average of (0.055) among similar stocks. P/S Ratio (4.143) is also within normal values, averaging (18.367).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of airborne, ground and command, control and communication electronic systems
Industry AerospaceDefense